申请人:ONO PHARMACEUTICAL CO., LTD.
公开号:EP3112368A1
公开(公告)日:2017-01-04
Compounds represented by general formula (I) as drawn below (all of the symbols in the formula conform to the definitions in the Description) are compounds that, in addition to having a Btk-selective inhibitory activity, exhibit an excellent metabolic stability and can avoid hepatotoxicity or the like, and as a consequence can provide safe therapeutic agents for diseases in which B cells or mast cells participate.
下图中通式(I)所代表的化合物(式中所有符号均符合说明中的定义),除了具有 Btk 选择性抑制活性外,还具有极佳的代谢稳定性,可避免肝毒性等,因此可为 B 细胞或肥大细胞参与的疾病提供安全的治疗剂。